SCHEMBL3523734

SCHEMBL3523734

CON(C)C(=O)CCCCCCCCCCCCCCCO

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 1/20 0.43
FFAR1 O14842 1/20 0.43
FFAR4 Q5NUL3 1/20 0.43
KDM4E B2RXH2 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
ALDH1A1 P00352 2/20 0.35
CYP4F2 P78329 2/20 0.35
CYP4A11 Q02928 2/20 0.35
GAA P10253 1/20 0.35
KDM5A P29375 2/20 0.35
FNTA P49354 1/20 0.34
FNTB P49356 1/20 0.34
KDM4A O75164 9/20 0.34
KDM4C Q9H3R0 9/20 0.34
KDM7A Q6ZMT4 1/20 0.34
PHF8 Q9UPP1 1/20 0.34
KDM2A Q9Y2K7 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27139253 1.00 GPR84 (0.43) GPR84FFAR1FFAR4KDM4ESMN1; SMN2
SCHEMBL21645392 1.00 GPR84 (0.43) GPR84FFAR1FFAR4KDM4ESMN1; SMN2
SCHEMBL499152 0.98 GPR84 (0.39) GPR84FFAR1FFAR4KDM4ESMN1; SMN2
SCHEMBL6541852 0.91 CAMK2A (0.39) GPR84FFAR1FFAR4KDM4ESMN1; SMN2
SCHEMBL29991123 0.91 ALDH1A1 (0.41) ALDH1A1KDM5AKDM4AKDM4CKDM7A
SCHEMBL24703880 0.89 ALDH1A1 (0.42) ALDH1A1KDM5AKDM4AKDM4CKDM7A
SCHEMBL22205611 0.84 LMNA (0.44) ALDH1A1KDM5AKDM4AKDM4CKDM7A
SCHEMBL3963400 0.83 ALDH1A1 (0.50) GPR84FFAR1FFAR4ALDH1A1KDM5A
SCHEMBL8142273 0.83 ALDH1A1 (0.50) GPR84FFAR1FFAR4ALDH1A1KDM5A
SCHEMBL2304549 0.83 ALDH1A1 (0.50) GPR84FFAR1FFAR4ALDH1A1KDM5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7691900-B2 Tocopherol derivatives with a long hydroxylated chain, which can be used as neurotrophics AXOGLIA THERAPEUTICS S.A. (LU) 2010-04-06 US disclosed
US-20070105946-A1 Tocopherol derivatives with a long hydroxylated chain, which can be used as neurotrophics UNIVERSITE LOUIS PASTEUR (FR) 2007-05-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070105946-A1 Tocopherol derivatives with a long hydroxylated chain, which can be used as neurotrophics BDNF, GMFG, NGF GPR84 337/4885FFAR1 220/4885FFAR4 240/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.